Skubal's Experimental Surgery Reopens the Tigers' Timeline Question

Tarik Skubal threw 40 pitches across three innings in a simulated game on Tuesday, the latest checkpoint in an unprecedented recovery arc. The two-time AL Cy Young winner underwent surgery earlier this month to remove a loose body from his elbow using a NanoNeedle device—a minimally invasive tool that, while theoretically faster than traditional arthroscopy, has never been tested on an MLB pitcher before. Detroit is offering no timeline, and for good reason: they're navigating uncharted territory.

The conventional playbook for loose-body elbow surgery runs three months minimum, often longer. Skubal's smaller incision and reduced tissue trauma create a legitimate path to a faster return, but that's medical theory, not baseball fact. A June return feels speculatively possible; July feels more realistic; nobody's betting their farm on either. The real problem isn't just Skubal's timeline—it's the cascade of failures that have made his absence so catastrophic. Detroit sat 18-17 and tied for the AL Central lead when Skubal went down on May 4th. They've since collapsed to 22-34, hemorrhaging eight games in little more than three weeks. Even with a weak AL field, five games back from a playoff spot doesn't count for much when your rotation is a disaster zone.

Justin Verlander threw 66 pitches in four innings yesterday and is progressing toward a rehab assignment, but he too is on his own unpredictable clock after hip inflammation derailed his season before it started. Jackson Jobe, Reese Olson, and Ty Madden are all sidelined. More immediately, Casey Mize departed yesterday's start after four innings with groin tightness—the same injury that shelved him for three weeks in late April and May. That's not a new problem; that's a recurring one. If Mize returns to the IL, Detroit dips into Sawyer Gipson-Long and Jake Miller. At that point, they're not competing; they're surviving.

From a betting standpoint, the Tigers' win total is the first domino. Their preseason over/under was built around a healthy rotation and a Skubal-led pennant run. Every week Skubal remains unavailable, that season projection decays. Unders on Detroit's season win total gain value with each passing day, particularly if Mize's groin becomes a chronic limitation or if Verlander's return stalls. Short-term, game-by-game play against Detroit pitching becomes a contrarian angle: the market is slow to adjust to rotation injuries because the eye gravitates to names, not availability. When Gipson-Long or Miller starts, sharps often exploit public overvaluation of Tigers innings. The opponent team total over is worth monitoring if Detroit's fourth-starter depth takes another hit.

Skubal's return—whenever it lands—will reset the whole calculus. Until then, this is a team operating on fumes. The experimental surgery is encouraging in isolation. In the context of a 22-34 record and a skeletal rotation, it's a single bright spot in an otherwise grim May.